Abstract: A method of enhancing lucid dreaming comprising administration to individuals the Acetylcholine Esterase inhibitor class of drugs. Use of therapeutic agents recently developed for Alzheimer”s Disease such as Donepizil (Aricept®), Rivastigmin (Exelon®), Galantamine (Reminyl®, Nivalin®), and Huperzine results in minimal side-effects (e.g., insomnia and gastrointestinal symptoms) while significantly enhancing dreaming cognitive clarity, lucidity, self-reflection, recall, control, bizarreness, and visual vividness.

Abstract: Equipment and methods employed to assist people to achieve lucid dreams (dreams in which one is aware that one is dreaming) function by detecting and monitoring the eye and head movements of sleeping persons for the presence of sufficient eye movement activity in the absence of head movement to indicate the presence of REM sleep and then applying sensory stimuli to sleepers in REM sleep, which if incorporated into their dreams, can cue them that they are dreaming without producing awakening. With this equipment and methods, people are able to have more lucid dreams than they otherwise would. A preferred embodiment includes a face mask that contains two infrared emitter-detector pairs, one for sensing eye movements and one for sensing body movements, a state-test button, and components that produce low intensity sensory stimuli such as light and sound.